Cardinal Health (NYSE: CAH), Dublin, OH, reported sales for the fiscal 2016 second quarter ended Dec. 31 of $31.4 billion, a 23.1 percent increase compared to the same period a year ago. Profit increased 13 percent to $326 million.

Pharmaceutical segment sales increased 25 percent year-over-year to $28.3 billion due to growth in the base of existing customers as well as the impact of new customers. Segment profit increased 16 percent to $627 million, also drive by continued growth from existing and new customers, as well as acquisitions.

For the first six months, Cardinal Health reported sales of $59.5 billion, a 20 percent increase compared to the same period a year ago. Profit increased 28 percent to $710 million.